Findings suggest that triapine radiochemotherapy provides improved cancer-related survival in women with stage IIIB cervical cancer.
(P028) Efficacy and Tolerability of Chemoradiation for Lymph Node-Positive Cutaneous Nonmelanoma Skin Cancer
The efficacy and tolerability of chemoradiation (CRT) for locoregionally advanced cutaneous nonmelanoma skin cancer (NMSC) are investigated.
(P141) Dosimetric Comparison of Volumetric-Modulated Arc Therapy With Step-and-Shoot Intensity-Modulated Radiation Therapy for Prostate Cancer
Step-and-shoot intensity-modulated radiation therapy (IMRT) and variable-dose-rate volumetric modulated arc therapy (VMAT) are two common treatment techniques for the definitive treatment of prostate cancer. In order to compare these two techniques in modern practice, we analyzed two cohorts of patients treated at our institution who were matched for PTV, prescribed dose, and patient characteristics.
(P072) Reducing Radiation Dose to the Breast in Female Patients Undergoing Stereotactic Body Radiotherapy for Lung Cancer
Stereotactic body radiotherapy (SBRT) is gaining prominence as an effective treatment for early-stage inoperable non–small-cell lung cancer (NSCLC). To date, little attention has been paid to the radiation dose delivered to the breast tissue in female patients.
(P140) Comparison of Split-Field IMRT With Whole-Field VMAT and IMRT for Locally Advanced Head and Neck Cancer
Advances in intensity-modulated radiation therapy (IMRT) head and neck target delineation and treatment planning have led to improved sparing of organs at risk (OARs). In this study, we compare three IMRT techniques for the treatment of common cases of oropharyngeal squamous cell carcinoma.
(P071) SBRT Treatment of Central Chest Lesions: Experience at the University of California, San Francisco
Early experiences with stereotactic body radiotherapy (SBRT) for treatment of intrathoracic lesions have demonstrated excellent local control rates, upwards of 90% for primary and metastatic lesions in the lung parenchyma. We describe our institutional experience with SBRT treatment of central lung lesions and patient outcomes.
(P138) Yttrium-90 Radioembolization for Liver Metastasis From Neuroendocrine Cancer: A Single-Institution Retrospective Review
This retrospective analysis concentrates on our institutional experience with transarterial radioembolization (TARE) for the treatment of liver metastasis from neuroendocrine cancer.
(P027) Salvage of ‘Low-Risk’ Oral Tongue Failures Initially Managed With Surgery Alone—Importance of Recurrent Stage
Adjuvant therapy is not recommended after resection of oral tongue cancer in the absence of risk factors for recurrence. Having reported a 73% locoregional control rate for patients managed with surgery alone for ‘low-risk’ oral tongue cancer, this series examines our experience treating locoregional failures.
Repeat radiation for recurrent brain tumors may be performed in the pediatric population with acceptable short- and long-term toxicity. Establishment of dose-volume guidelines will facilitate treatment planning for these challenging cases.
There is conflicting evidence regarding the benefit of postmastectomy radiation therapy (PMRT) for pathologic stage T3N0M0 breast cancers. We performed a Surveillance, Epidemiology, and End Results (SEER) analysis to investigate the benefit of PMRT in these patients.